drugset / Trial / NCT02536209

A Study to Investigate the Pharmacodynamic Effect of Single Doses of MT-8554 in Healthy Subjects

NCT02536209

Phase 1 Completed 20 enrolled Tanabe Pharma Corporation
RandomizedCrossoverDouble-blindOther

Summary

The purpose of this study is to investigate the pharmacodynamic effect of single doses of MT-8554 in healthy subjects.

Timeline

Start
2015-08
Primary completion
2015-11
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Elismetrep Small molecule
Subject Oxycodone Other / unclassified

Indications

No indication recorded.